$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
索拉非尼要注意什么呢?
2025-10-19 11:44:20
Check Details
索拉非尼治疗肾癌治疗效果如何?
2025-10-19 11:44:20
Check Details
索拉非尼去哪里购买?
2025-10-19 11:44:20
Check Details
索拉非尼作用以及功效
2025-10-19 11:44:20
Check Details
索拉非尼可以治什么?
2025-10-19 11:44:20
Check Details
索拉非尼获批的三大适应症
2025-10-19 11:44:20
Check Details
索拉非尼要注意哪些事?
2025-10-19 11:44:20
Check Details
多吉美(索拉非尼)要注意什么?
2025-10-19 11:44:20
Check Details
多吉美(索拉非尼)纳入医保了吗?
2025-10-19 11:44:20
Check Details
多吉美(索拉非尼)上市了没?
2025-10-19 11:44:20
Check Details
多吉美哪有售卖?
2025-10-19 11:44:20
Check Details
多吉美治疗效果如何?
2025-10-19 11:44:20
Check Details
1
2
...
2209
2210
2211
2212
2213
2214
2215
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
2
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
3
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
4
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
5
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
6
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
7
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
8
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
9
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
10
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
11
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
12
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment